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In the brain, mitochondrial metabolism has been largely associated with energy
production, and its dysfunction is linked to neuronal cell loss. However, the functional
role of mitochondria in glial cells has been poorly studied. Recent reports have
demonstrated unequivocally that astrocytes do not require mitochondria to meet their
bioenergetics demands. Then, the question remaining is, what is the functional role of
mitochondria in astrocytes? In this work, we review current evidence demonstrating
that mitochondrial central carbon metabolism in astrocytes regulates overall brain
bioenergetics, neurotransmitter homeostasis and redox balance. Emphasis is placed
in detailing carbon source utilization (glucose and fatty acids), anaplerotic inputs and
cataplerotic outputs, as well as carbon shuttles to neurons, which highlight the metabolic
specialization of astrocytic mitochondria and its relevance to brain function.
Keywords: glycolysis, astrocytes, bioenergetics, redox, fatty acid oxidation, cataplerotic, anaplerotic,
mitochondria
INTRODUCTION
The central nervous system (CNS) is a complex, integrated structure composed of diverse cell types.
Neurons are highly specialized cells in charge of transmitting, processing, and storing information
and thus have been considered the functional units of the CNS. However, research within the last
few decades has demonstrated the critical roles non-neuronal cells play in CNS function. The non-
neuronal cells of the CNS include macroglia (astrocytes, ependymal cells and oligodendrocytes)
and microglia, which support essential functions such as the maintenance of neurotransmitter
communication, metabolism, trophic support, formation of myelin sheath, wound healing, and
immune surveillance (von Bernhardi et al., 2016).
Astrocytes originate from the neuroectoderm. Recent estimates suggest they account for between
19 and 40% of the glial population (with an estimated glial to neuron ratio of ∼1:1), and a
strong regional variation within the CNS (von Bartheld et al., 2016). Astrocytes are a heterogenous
population of cells with a diverse array of morphological, functional and molecular properties
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(Garcia-Marin et al., 2007). While the cellular identity of
astrocytes is determined by their gene expression profile post-
differentiation (intrinsic patterning) (Song et al., 2002; Krencik
et al., 2011), the surrounding environment and neuronal circuitry
further shapes, modifies, and maintains the form and functions
of differentiated astrocytes (extrinsic factors) (Koulakoff et al.,
2008; Yang et al., 2009; Farmer et al., 2016; Ben Haim
and Rowitch, 2017). Structurally, astrocytes contain multiple
radial processes that create diverse interfaces with other glia,
neurons, and capillary endothelial cells. Astrocytes’ fine processes
and endfeet envelope neuronal cell bodies, synapses, and
blood vessels. In addition, an intracellular interface with other
astrocytes or oligodendrocytes is generated via gap junctions
(connexin channels), creating an extensive interconnected
network throughout the brain (Orthmann-Murphy et al., 2008).
Gap junctions exchange ions and small molecules between cells
(<1 kDa in size) including; inositol triphosphate (IP3), K+, Ca2+,
ATP, glucose, glutamate, glutathione (GSH), and cyclic AMP;
highlighting its signaling and buffering role within the CNS
(Figure 3) (Niessen et al., 2000; Goldberg et al., 2002; Bedner
et al., 2006; Lapato and Tiwari-Woodruff, 2018).
Astrocytes are involved in a number of processes associated
with brain function and disease progression. Astrocytes are major
secretory cells, releasing factors or transmitters (gliotransmitters)
including neurotransmitters (and their precursors), modulators,
peptides, hormones, trophic (growth) factors, and metabolites.
Astrocyte secreted factors have been shown to be involved in
synapse formation, function and plasticity, neuronal growth,
differentiation and survival, as well as in the regulation of
the vascular tone and blood flow in the brain. Astrocytes
have also been shown to mediate synaptic pruning by
phagocytosis (Chung et al., 2015; MacVicar and Newman, 2015;
Verkhratsky et al., 2016).
Abbreviations: ABCC1/MRP1, adenosine-triphosphate-binding cassette
transporter subfamily C member 1 or multidrug-resistance-associated protein
1; ABCD1, adenosine triphosphate binding cassette subfamily D member 1;
AcAc, acetoacetate; Ac-CoA acetyl-CoA; AcAc-CoA, acetoacetyl-CoA; ACAA2,
acetoacetyl-CoA hydrolase; ACAT1, acetyl-CoA C-acetyltransferase, acetoacetyl-
CoA thiolase II; ACC, acetyl-CoA carboxylase; ACD, acyl-CoA dehydrogenase
or ACAD; ACS, acyl-CoA synthetase; ACOT, acyl-CoA thioesterases; ACL,
ATP citrate lyase; ADP, adenosine diphosphate; AGC, aspartate/glutamate
carrier antiporter or Aralar 1; ALAT, alanine aminotransferase; ALDH1L,
10-formyl-THF dehydrogenase; AMP, adenosine monophosphate; AMPA-R,
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; AMPK,
adenosine monophosphate activated protein kinase; ANLS, astrocyte-neuron
lactate shuttle; ANT, adenine nucleotide transporter; ApN, aminopeptidase
N; ApoE/D, apolipoprotein E/D; ATP, adenosine triphosphate; BBB, blood-
brain barrier; BCAA, branched chain amino acids; BCAT, branched chain
aminotransferases; BDH, β-hydroxybutyrate dehydrogenase; BHMT, betaine-
homocysteine S-methyltransferase; CACT, carnitine/acylcarnitine translocase;
cAMP, cyclic adenosine monophosphate; CAT, catalase; CACT, carnitine-
acylcarnitine translocase; CIC, citrate/isocitrate carrier; Cdk5, cyclin-dependent
kinase 5; CNS, central nervous system; CNTF, ciliary neurotrophic factor;
CoA, coenzyme A; Cox10, cytochrome C oxidase assembly factor heme A;
CPT, carnitine palmitoyltransferase; CRAT, carnitine acetyltransferase; CROT,
carnitine octanoyltransferase; CysGly, l-cysteine-l-glycine; DHAP, dehydroacetone
phosphate; DIC, dicarboxylate carrier; DMG, dimethylglycine; EAAT, excitatory
amino acid transporter; ECH, enoyl-CoA hydratase; ETC, electron transport
chain; ETF, electron transferring flavoprotein; FA, fatty acid; FAD+(FADH2),
flavin adenine dinucleotide; FAO, fatty acid oxidation; FAT/CD36, fatty acid
translocase; FATP, fatty acid transport protein; FBP, fructose 1,6-biphosphatase;
FRα, folate receptor α or FOLR1; FT, folate transporters; GABA, γ-aminobutyric
Astrocytes become “reactive” as a response to pathological
conditions or to perturbations in cellular homeostasis. Astrocyte
reactivity is a loose term that primarily refers to an enlargement
in the cell body and processes (hypertrophy), and an increase
in the levels of the glial fibrillary acidic protein (GFAP), that
relates to a pathological stimulus in the CNS. Unlike microglia,
reactive astrocytes are not believed to be proliferative outside of
conditions of glial scar formation, which is a specific, irreversible
form of astrocyte reactivity. Reactive astrocytes contribute to the
production and release of cytokines and the neuroinflammatory
process during injury and neurodegeneration. Reactive astrocytes
should not be confused with activated astrocytes, as the
latter pertains to astrocyte responses to neurotransmission
(Ben Haim et al., 2015).
Astrocytes can also be considered the master regulators
of brain metabolism. In this review paper, we discuss the
acid; GABA-T, γ-aminobutyric acid transaminase; GAD, glutamate decarboxylase;
GAT, γ-aminobutyric acid transporter; GC1/2, glutamate carrier or SLC25A18/22;
GDH, glutamate dehydrogenase; GFAP, glial fibrillary acidic protein; GLAST,
glutamate aspartate transporter or excitatory amino acid transporter 1; GlcNAc,
N-acetylglucosamine; GLDC, glycine decarboxylase; GLS, glutaminase; GLT-
1, glutamate transporter 1 or excitatory amino acid transporter 2; GLUT,
glucose transporter; GlyT1, sodium-chloride-dependent glycine transporter 1;
GOT1, cytosolic aspartate aminotransferase; GOT2, mitochondrial aspartate
aminotransferase; GS, glutamine synthetase; GSH, glutathione; GSSG, glutathione
disulfide (oxidized); G3P, glyceraldehyde 3-phosphate; G6PC, glucose 6-
phosphatase; G6PD, glucose 6-phosphate dehydrogenase; γGT, γ-glutamyl
transpeptidase; HAD, 3-hydroxyacyl-Coenzyme A dehydrogenase; HADHA/B,
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit
α/β; (βHB, (β-hydroxybutyrate; HIF-1(α, hypoxia-inducible factor-1(α; HMCS1,
(β-hydroxy-(β-methyl glutaryl-CoA synthase; HMGCL, (β-hydroxy-(β-methyl
glutaryl -CoA lyase; 2-HPCL, 2-hydroxyphytanoyl-CoA lyase; H2O2, hydrogen
peroxide; IDH, isocitrate dehydrogenase; IMS, mitochondrial permeability
transition pore; IP3, inositol triphosphate; (KG, (α-ketoglutarate; LCFAs, long
chain fatty acid; LD, lipid droplet; LDH, lactate dehydrogenase; MCFAs, medium
chain fatty acids; MCT, monocarboxylate transporter; ME, malic enzyme;
MPC1, mitochondrial pyruvate carrier; MTHFD(L), methylenetetrahydrofolate
dehydrogenase 2 (like); mPTP, mitochondrial permeability transition pore;
Na+/K+, ATPase sodium-potassium adenosine triphosphatase; NAD+(NADH),
nicotinamide adenine dinucleotide; NADP+(NADPH), nicotinamide adenine
dinucleotide phosphate; NDUFS1, nicotinamide adenine dinucleotide ubiquinone
oxidoreductase core subunit S1; NMDA-R, N-methyl-d-aspartate receptors;
NNT, nicotinamide nucleotide transhydrogenase; Nox, NADPH-dependent
oxidases; Nrf2, nuclear factor erythroid-2-related factor 2; OAA, oxaloacetate;
OGC, 2-oxoglutarate/malate carrier; 3-OHacyl-CoA, 3-hydroxyacyl-Coenzyme
A; OXCT1, 3-oxo-acid-CoA transferase; OXPHOS, oxidative phosphorylation;
O2•−, superoxide anion; P, phosphate; PAG, phosphate-activated glutaminase;
PC, pyruvate carboxylase; PCFT, proton-coupled folate transporter or SLC46A1;
PDH, pyruvate dehydrogenase; PDK, pyruvate dehydrogenase kinase; PEP,
phosphoenolpyruvate; PEPCK, phosphoenolpyruvate carboxykinase; PFK1,
phosphofructokinase 1; PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase-3; 6PG, 6-phosphogluconate; PhyH/Pahx, phytanoyl-CoA
hydroxylase; PPAR, peroxisome proliferation activated receptor; PPP, pentose
phosphate pathway; Prop-CoA, propionyl-CoA; PUFA, poly-unsaturated
fatty acid; Q, ubiquinone; Redox, reduction-oxidation; RET, reverse electron
transfer; RFC, reduced folate carrier or SLC9A1; ROS, reactive oxygen
species; 5RP, ribulose-5 phosphate; SAH, S-adenosylhomocysteine; SAM,
S-adenosylmethionine; SCFAs, short chain fatty acids; SFXN1, sideroflexin 1 or
mitochondrial serine transporter; SHMT, serine hydroxymethyltransferase; SNAT,
sodium-coupled neutral amino acid transporter; SSA, succinate semialdehyde;
SSADH, succinate semialdehyde dehydrogenase; SOD, superoxide dismutase;
Succ-CoA, succinyl-CoA; TCA, cycle tricarboxylic acid or Krebs cycle; THF,
tetrahydrofolate; TSP, trans-sulfuration pathway; UDP, uridine diphosphate; UTP,
uridine triphosphate; VDAC, voltage-dependent anion channel; VGAT, vesicular
GABA transporter; VGLUT, vesicular glutamate transporter; VLCFA, very
long chain fatty acid; XAG-/EAAT3, aspartate-glutamate transporter; Xc-/xCT,
cystine-glutamate exchanger; X-CH3, Methylated substrate.
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importance of astrocytes’ metabolism in the regulation of
neurotransmitter recycling and synthesis, central carbon
metabolism and bioenergetics, as well as redox homeostasis
and antioxidant/xenobiotic defense. Our goal is to highlight the
metabolic niche astrocytes fill within overall brain metabolism.
ASTROCYTES’ METABOLISM AND
BIOENERGETICS: A GLYCOLYTIC CELL
While the mass of the human brain accounts for approximately
2% of total body weight, its oxidative metabolism accounts for
∼20% of the body’s total (Rolfe and Brown, 1997; Attwell and
Laughlin, 2001). Most of this oxidative energy (∼75–80%) is
utilized at the synapse to maintain and restore ionic gradients,
and for the uptake and recycling of neurotransmitters (Riveros
et al., 1986; Wong-Riley, 1989; Attwell and Laughlin, 2001;
Hyder et al., 2013; Figure 3.4). By comparison, the metabolic
processes in astrocytes have been estimated to account for
between 5 and 15% of the total ATP expenditure in the
brain (Attwell and Laughlin, 2001; Belanger et al., 2011).
Glucose is the primary energy substrate in the adult brain,
however, alternate energy sources can fuel brain function. Lactate
transport across the blood-brain barrier (BBB) (Figure 3.1)
provides ∼8–10% of the brain’s energy requirements under
basal conditions (Boumezbeur et al., 2010), and it has
been estimated to supply ∼20–25% of energy during energy
demanding activities (van Hall et al., 2009). As plasma
lactate concentrations rise, lactate uptake in the CNS increases
coinciding with a decrease in glucose uptake (Smith et al.,
2003; van Hall et al., 2009). When required, an important
pool of lactate is always available as the extracellular levels
of lactate (0.5–1.5 mM) are similar to those of glucose
(Magistretti and Allaman, 2015).
Metabolism in astrocytes and neurons is interconnected, and
it has been clearly demonstrated that neurons depend upon
astrocytes for a variety of metabolic processes. The in vivo
energy demands of astrocytes can be fulfilled in the absence of
oxidative phosphorylation (OXPHOS), with an observed increase
in lactate production in mutants of Cox10 (part of the cytochrome
c oxidase complex and required for complex IV function),
indicating that astrocytes are glycolytic (Figures 1.1, 3.2; Supplie
et al., 2017). Glucose has been reported as being the preferential
energy substrate of astrocytes over lactate, though glucose uptake
does not match the theoretical bioenergetic output (Bouzier-
Sore et al., 2006; Jakoby et al., 2014). Inside the cell, glucose
is phosphorylated generating glucose-6-phosphate (P), which is
subsequently converted to fructose-6P. Glucose-6P can also be
used for glycogen synthesis or in the pentose phosphate pathway
(PPP) (Figure 1.1), while fructose-6P can be either metabolized
to pyruvate or initiate the hexosamine pathway with uridine
diphosphate (UDP)-N-acetylglucosamine (GlcNAc) as its final
product and mediator of protein GlcNAcylation (Goncalves et al.,
2018). Downstream of glycolysis, glyceraldehyde-3P (G3P) can
be metabolized for de novo synthesis of serine (Figure 1.1).
Serine is also a precursor for the synthesis of glycine (folate
cycle) and cysteine (through the trans-sulfuration pathway, TSP)
(Figures 1.1, 4.4, 4.5), both of which contribute to the production
of GSH (Figure 3.2), which is essential for redox buffering.
Serine and glycine are major sources for the transfer of one-
carbon units through folate intermediates for their use in purine
and thymidylate synthesis, nicotinamide adenine dinucleotide
phosphate (NADPH) production and methylation reactions
(Figure 4.4; Yang and Vousden, 2016).
Pyruvate entry into the tricarboxylic acid (TCA or Krebs)
cycle (Figure 2.1) is limited by a reduced activity of pyruvate
dehydrogenase (PDH) in astrocytes due to its phosphorylation
via pyruvate dehydrogenase (PDK) (Bouzier-Sore et al., 2006;
Halim et al., 2010; Jakoby et al., 2014), creating a surplus
of pyruvate due to the high levels of glucose consumption
(Figure 1.2). In contrast to astrocytes, glycolysis in neurons is
restricted by the continuous degradation of 6-phosphofructo-2-
kinase/fructose-2, 6-bisphosphatase-3 (PFKFB3), which catalyzes
the synthesis of fructose-2,6-P an allosteric activator of
phosphofructokinase 1 (PFK1) (Almeida et al., 2004; Herrero-
Mendez et al., 2009). Accordingly, glucose utilization in neurons
is directed to PPP in order to regenerate NADPH for the
reductive recycling of GSH upon oxidative stress (Figure 3.3;
Delgado-Esteban et al., 2000; Vaughn and Deshmukh, 2008;
Herrero-Mendez et al., 2009; Bolanos, 2016). The astrocyte-
neuron lactate shuttle (ANLS) hypothesis states that a large
portion of glucose metabolism in astrocytes is directed to lactate
production and this is subsequently shuttled to neurons as
fuel for OXPHOS (Figures 3.2, 3.3; Pellerin and Magistretti,
1994; Magistretti and Allaman, 2015; Machler et al., 2016;
Gonzalez-Gutierrez et al., 2019). This shuttle seems to involve
sequestration within the endoplasmic reticulum for its delivery
from perivascular endfeet to perisynaptic processes (Muller et al.,
2018). Under hypoxic conditions astrocytes have the ability to
upregulate glycolytic enzymes including the monocarboxylate
transporter MCT4 involved in the transfer of lactate to
neurons via the activation of the hypoxia-inducible factor-
1α (HIF-1α) (Rosafio and Pellerin, 2014). Nitric oxide can
also upregulate glucose transporter-1 (GLUT1), hexokinase-
2 and MCT4 via HIF-1α (Brix et al., 2012). However,
other studies have reported that selective loss of HIF-1α in
astrocytes protects neurons from hypoxic injury (Vangeison
et al., 2008). Recent studies also demonstrate that during energy-
demanding conditions or aging neurons have the capacity to
upregulate glucose metabolism, and these findings have been
used to argue against the ANLS hypothesis (Figure 3.3; Patel
et al., 2014; Lundgaard et al., 2015; Diaz-Garcia et al., 2017;
Drulis-Fajdasz et al., 2018).
Astrocytes also store energy in the form of glycogen, which
can be broken down to lactate. Yet due to the limited amount
of glycogen stored in astrocytes (∼3–12 µmol per g of tissue,
1–6% of total glucose; Choi et al., 1999), its contribution to the
maintenance of either neuronal or astrocyte energy-dependent
processes under stress conditions is still unclear (Bak et al.,
2018). There is strong evidence supporting a robust oxidative
metabolic capacity in astrocytes (1/3 of total brain glucose and 1/2
of total brain lactate oxidative metabolism) (Zielke et al., 2009).
Frontiers in Neuroscience | www.frontiersin.org 3 November 2020 | Volume 14 | Article 536682
fnins-14-536682 October 30, 2020 Time: 15:47 # 4
Rose et al. Astrocytes’ Mitochondrial Metabolism and Brain Function
FIGURE 1 | Central carbon metabolism in astrocytes. (1.1) In astrocytes, glucose is used via glycolysis as a principal energy source. The PPP creates redox
potential by replenishing the NADPH pool. Glucose storage in glycogen is restricted or transient at most. Glucose carbons can also be used for cysteine (Cys, via
TSP) and glycine (Gly) synthesis using serine (Ser) as a precursor. Gluconeogenesis (green broken arrows) is astrocyte-specific as they express FBP and G6PC but it
requires metabolism of OAA to PEP in the mitochondria. (1.2) Pyruvate is the principal end product of glycolysis in astrocytes. Astrocytes convert most pyruvate into
lactate by LDH5 to be exported to the extracellular space. Pyruvate also enters the mitochondria (see Figure 2 for details). (1.3) FAs are sorted by their size: 12 or
less carbons can directly enter the mitochondria (SCFAs or MCFAs), 13–21 carbons (LCFAs) pass into the mitochondria through a shuttle (see Figure 2 for details),
and 22+ carbons (VLCFAs) enter peroxisomes to create shorter FA products through α/β-oxidation. The esterification of FAs (ACS) limits their ability to pass through
membranes, and is required for FAO. (1.4) Peroxisomal α/β-oxidation occurs in a similar manner to mitochondrial FAO but, without an ETC, FADH2 donates its
electrons directly to O2 to create H2O2 that is neutralized by CAT. Multiple mechanisms of FA transport systems exist within peroxisomes, each with different affinities
for various FA lengths. Exported FAs enter the mitochondria to complete FAO. (1.5) Ketone bodies in astrocytes can enter as substrates for mitochondrial
metabolism (see Figure 2 for details) or can be the end product in mitochondrial metabolism that astrocytes export for other cells (neurons). (1.6) Astrocytes utilize
glutamate (Glu) for glutamine (Gln) synthesis (Glu-Gln cycle), Cys acquisition (xCT or EAAT3), and for GSH synthesis, this later exported via (MRP1). In astrocytes, Glu
is imported from the synaptic cleft by EAAT1/2 or derived from transamination of the mitochondrial TCA intermediate αKG by aspartate (Asp) amino transferases
(GOT1/2). Glu can also be used to power the malate (Mal)-Asp shuttle through AGC, or enter the mitochondria as a substrate for OXPHOS (see Figure 2 for details).
Microarray and proteomic analyses have shown that most
enzymes in the TCA cycle are expressed at higher levels in
astrocytes than in neurons, and immuno-electron microscopy
revealed that mitochondria is present at higher density in fine
astrocytic processes encompassing synapses (Figure 3.6; Lovatt
et al., 2007). Nevertheless, astrocytes deficient in mitochondrial
respiration survive as glycolytic cells, both in vitro and in vivo
(Supplie et al., 2017). What then is the physiological importance
of mitochondrial metabolism in astrocytes? We next discuss
the particularities of mitochondrial central carbon metabolism





Oxidative metabolism in mitochondria is primarily
fueled by pyruvate, fatty acids (FAs)/ketone bodies, and
Frontiers in Neuroscience | www.frontiersin.org 4 November 2020 | Volume 14 | Article 536682
fnins-14-536682 October 30, 2020 Time: 15:47 # 5
Rose et al. Astrocytes’ Mitochondrial Metabolism and Brain Function
FIGURE 2 | Mitochondrial metabolism in astrocytes. (2.1) The astrocyte TCA cycle is principally used for biosynthetic processes, not OXPHOS. Synthesis of Ac-CoA
from pyruvate is limited by the phosphorylation (P) of PDH. Cataplerotic reactions of the TCA cycle are matched by anaplerotic carbon inputs. Anaplerotic inputs in
astrocyte include pyruvate carboxylatyion to OAA; Ac-CoA and Succ-CoA synthesis from FAO and ketolysis; and metabolism of glutamate to αKG via transamination
reactions or by the activity of GDH. Astrocyte cataplerotic outputs include PEP (gluconeogenesis) αKG, malate (Mal), and citrate (Cit). Fum, fumarate. (2.2) FAO
produces Ac-CoA and Prop-CoA that are directed to either ketogenesis, ketolysis, or as anaplerotic input to the TCA cycle. FAO generates a high yield of NADH and
FADH2 (see 2.5). (2.3) Ketogenesis condenses Ac-CoA to either AcAc or βHB. FAO is the principal source of ketogenesis in astrocytes. Ketolysis reverses this
process, requiring Succ-CoA from either Prop-CoA (FAO or BCAA metabolism), or the TCA cycle as a driving force. (2.4) Mitochondrial Glu synthesis and
incorporation into the TCA cycle in astrocytes is performed by transamination (GOT2, ALAT, BCAT) or by deamination (GDH, GLS, GABA-T) of αKG allowing
glutamate to act in both cataplerosis and anaplerosis. (2.5) The astrocyte ETC is not required for survival, and its activity has been reported to be a source of ROS
due to inefficient complex activity and electron transfer. Importantly, high yield of NADH and FADH2 generated from FAO (see 2.2) can increase ROS formation due to
the transfer of electrons from FADH2 to ETF, creating a backpressure of electrons flowing from complex I. (2.6) While the outer mitochondrial membrane is fairly
permeable, numerous transporters exist on the inner membrane to facilitate entry and exit of a number of metabolites from the mitochondrial matrix.
glutamine/glutamate. Pyruvate generated from glycolysis is
actively transported into the mitochondrial matrix via the
mitochondrial pyruvate carrier (MPC1) to be subsequently
decarboxylated and combined with coenzyme A (CoA)
(Figure 2.1). Oxidative decarboxylation of pyruvate to acetyl-
CoA (Ac-CoA) is mediated by PDH and is coupled to the
reduction of nicotinamide adenine dinucleotide (NAD+) to
NADH. Subsequently, citrate synthase catalyzes the condensation
of oxaloacetate (OAA) with Ac-CoA to generate citrate. Pyruvate
decarboxylation is the primary carbon source for the TCA
cycle and is sufficient to sustain oxidative carbon flux during
energy consumption, as the last step in the cycle regenerates
OAA to be combined further with another Ac-CoA molecule
generated by PDH (a closed loop) (Figure 2.1). However,
TCA cycle intermediates also provide precursors for the
biosynthesis of several classes of molecules. TCA intermediates
leave the cycle via cataplerotic reactions linked to biosynthetic
processes, while anapletoric reactions supplement carbons back
into to the TCA cycle. A balance between anaplerosis and
cataplerosis controls the entry and exit of carbons into the TCA
cycle, and is essential for biosynthetic processes (Figure 2.1;
Owen et al., 2002).
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FIGURE 3 | Neuronal-astrocytic metabolic cooperation. (3.1) GLUTs (glucose), MCTs (lactate and ketone bodies), and FATPs (FAs) facilitate the transport of carbon
sources across the BBB. 5-methylTHF is the predominant form of folate in the blood and its transport across the BBB is mediated by different folate transporters
(FT). (3.2) Astrocytes utilize glucose for the production of ATP (glycolysis), regeneration of NADPH (PPP), and to feed mitochondrial biosynthetic processes.
Astrocytes synthesize and export GSH (MRP1), lactate (MCT1/4), ketone bodies (MCT1/2), and glutamine (Gln) (SNAT5) that can be utilized by neurons for energy
production and synthesis of neurotransmitters. (3.3) Neurons utilize glucose primarily for the regeneration of NADPH (PPP), with some studies suggesting that
glycolysis can be upregulated during energy-demanding conditions. Lactate and ketone bodies are used in ATP production (OXPHOS). Neurons import GSH
precursors from astrocytes via EAATs and GlyT1, lactate and ketone bodies via MCT1/2, and Gln through SNAT1/2/7. (3.4) Upon their release into the synaptic cleft
Glu and GABA neurotransmitters can be uptaken into neurons via EAATs and the GABA transporter 1 (GAT1). However, astrocytes have a higher capacity to uptake
and metabolize these neuroransmitters. In astrocytes, GABA is metabolized in the mitochondria (see Figure 2.4). Glu is taken in by astrocytes (EAAT1/2), converted
to Gln (GS), and exported for neuronal uptake. In the neurons, Gln is converted to Glu via PAG and then Glu can be converted to GABA via GAD. Neurotransmitters
are subsequently loaded into vesicles via vesicular transporters (VGLUT or VGAT), which do not require ATP per se, but their activity is coupled to that of the vacuolar
H+ ATPase. The Na+/K+ ATPase maintains the electrochemical gradient required to sustain neuronal excitability (not shown) and in astrocytes it is essential to drive
neurotransmitter uptake. (3.5) During periods of excess Ac-CoA, lipid synthesis is initiated. Lipids are then transported to astrocytes in an apolipoprotein D/E
dependent manner, taken in by FATP1/4, and transferred into LDs. (3.6) In astrocytes, mitochondria co-localize on the plasma membrane with EAAT1/2, Na+/K+
ATPases, and glycolytic enzymes.
Pyruvate carboxylase (PC) is a major anaplerotic enzyme
in the mitochondria that generates OAA from pyruvate in an
ATP-dependent manner (Figure 2.1), replenishing carbons lost
by the export of OAA, citrate, and alpha-ketoglutarate (αKG)
from the TCA cycle, for gluconeogenesis, FA, and amino acid
synthesis, respectively (Figures 1.2, 1.6, 2.1, 2.6). It has been
estimated that 3–10% of glucose utilization in the brain is via
PC, and in astrocytes, 33–50% of pyruvate entering mitochondria
is utilized for anaplerotic reactions instead of producing energy
(Weber and Barros, 2015). Furthermore, the metabolism of
mitochondrial pyruvate through PC is reported to be 4.3-fold
higher (39.3 nmol/h/106 cell) than through PDH (9.1 nmol/h/106
cell) (Sa et al., 2017).
In astrocytes’ gluconeogenesis, OAA is converted
to phosphoenolpyruvate (PEP) in the mitochondria by
phosphoenolpyruvate carboxykinase (PEPCK2), as the cytosolic
activity of the cytosolic isoform (PEPCK1) has not been
detected (Figure 2.1; Schmoll et al., 1995). While PEP has been
shown to exit mitochondria (Garber and Ballard, 1969; Stark
et al., 2009), the precise mechanism has not been determined,
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FIGURE 4 | Mitochondrial carnitine shuttle, one-carbon folate metabolism and trans-sulfuration pathway. (4.1) Coenzyme A thioesters (Acyl-CoAs) cannot cross
mitochondrial membranes. CPT1a facilitates the transfer of the acyl group from CoA to carnitine. Acyl-carnitines are permeable to the outer mitochondrial
membrane, but not the inner mitochondrial membrane, requiring the transport via carnitine-acylcarnitine translocase (CACT) to reach the mitochondrial matrix. Once
in the matrix, CPT2 converts the acyl-carnitine back to an acyl-CoA, which can then undergo FAO (see Figure 2.2). The released carnitine is then transported back
across the inner mitochondrial membrane by CACT to be reused in the cytosol. (4.2) Non-esterified fatty acids of 12 or less carbons do not require the carnitine
shuttle system, and can diffuse across both mitochondrial membranes. However, they still require esterification to CoA by mitochondrial ACS before they can be
metabolized by FAO. (4.3) The carnitine shuttle system is regulated by malonyl-CoA, a precursor to FA synthesis which also inhibits CPT1a activity. Malonyl-CoA is
principally produced from citrate that is broken into OAA and Ac-CoA in the cytosol by ATP citrate lyase (ACL). The released acetyl-CoA is carboxylated by ACC to
malonyl-CoA. ACC is modulated by AMPK, which phosphorylates ACC and reduces its activity. (4.4) The folate pathway supports the transfer of one-carbon units
from serine for biosynthetic processes. During this process both MTHFD2(L) and ALDH1L2 generate NADPH, which is essential for mitochondrial redox
homeostasis. Despite the bidirectionality of this pathway, most of the cytosolic one-carbon units derived from serine are catabolized in the mitochondria. However,
when the mitochondrial folate pathway is lost the directionality of the cytosolic one-carbon flux is reversed to compensate the synthesis of NADPH. (4.5) In the
cytosol, MTHFD1 regenerates THF and the intermediate 5,10-methylene-THF links the folate pathway with the remethylation of homocysteine to methionine (Met)
within the TSP. In the liver and kidney mitochondria, BHMT regenerates Met, linking the mitochondrial oxidation of choline to betaine with the TSP, but the presence
of this pathway in brain cells has not been confirmed.
with the citrate/isocitrate carrier (CIC) and adenine nucleotide
transporter (ANT) being proposed as likely intermediators (Stark
and Kibbey, 2014). In the brain, gluconeogenesis is astrocyte-
specific as they express fructose 1,6-biphosphatase (FBP), which
generates fructose-6P from fructose-1,6P (Figure 1.1). Astrocytes
also express glucose 6-phosphatase (G6PC) (Figure 1.1), but
because they normally store glycogen, it has been suggested
that gluconeogenesis in astrocytes is primarily involved in
glycogenesis (Bernard-Helary et al., 2002), and that G6PC may
be silent under physiological conditions becoming activated at
times of stress (Ghosh et al., 2005). Gluconeogenesis in astrocytes
has been demonstrated with aspartate, glutamate, alanine, and
lactate as precursors and is becoming more recognized as an
important alternative source of glucose for neurons during stress
conditions (Yip et al., 2016).
In the brain, it has been long recognized that PC is primarily
expressed in astrocytes and to a lesser extent in microglia,
oligodendrocytes and ependymal cells (Shank et al., 1985; Murin
et al., 2009). However, as mentioned above, PDH activity
in astrocytes is reduced by its phosphorylation and thus an
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additional carbon source is proposed to exist to supplement
Ac-CoA to the TCA cycle (Figure 2.1; Halim et al., 2010). FA
oxidation (FAO) has been proposed to be the preferable pathway
for Ac-CoA synthesis in astrocytes (Figures 1.4, 2.2), but its
physiological implications are still unclear (Halim et al., 2010;
Adina-Zada et al., 2012; Panov et al., 2014).
KETOGENESIS AND KETOLYSIS
Ketone bodies are water-soluble molecules derived from FA
metabolism in the liver, supplying energy to peripheral tissues
including the brain. Ketone bodies have been shown to be
produced by astrocytes as well (Blazquez et al., 1998; Cullingford
et al., 1998; Guzman and Blazquez, 2001; Thevenet et al.,
2016). During starvation up to ∼70% of the brain’s energy
can be supplied by ketone bodies (Owen et al., 1967). Ketone
bodies are produced in the mitochondria from Ac-CoA in three
sequential steps mediated by: (1) Ac-CoA acetyltransferase 1
(ACAT1) also known as acetoacetyl (AcAc)-CoA thiolase or
thiolase II (Ac-CoA → AcAc-CoA, a reversible reaction); (2)
β-hydroxy-β-methyl glutaryl (HMG)-CoA synthase (HMCS1,
AcAc-CoA→ HMG-CoA); and (3) HMG-CoA lyase [HMGCL,
HMG-CoA → acetoacetate (AcAc)]. However, in astrocytes,
AcAc is primarily formed by the action of 3-oxo-acid-
CoA transferase (OXCT1 or SCOT) or AcAc-CoA hydrolase
(ACAA2) on AcAc-CoA and not by the action of HMGCL and
HMCS1 (Auestad et al., 1991). AcAc is then decarboxylated
to acetone or metabolized to β-hydroxybutyrate (βHB) via
βHB dehydrogenase (BDH) (Figure 2.3). Ketone bodies can
cross the BBB and plasma membranes via MCT1, 2 and 4
(Figures 1.5, 3.1, 3.4; Halestrap and Price, 1999; Morris, 2005).
At high concentrations, ketone bodies have been proposed to
support basal and activity-dependent needs of neurons and
glutamatergic signaling, while decreasing glucose utilization
(Lopes-Cardozo et al., 1986; Kunnecke et al., 1993; Sibson
et al., 1998; Magistretti et al., 1999; Chowdhury et al., 2014;
Courchesne-Loyer et al., 2017). Within the cell, ketone body
transport across the mitochondrial membrane has not been
fully characterized. While the mitochondrial pyruvate carrier
(MPC1) has been implicated in ketone body transport, inhibition
of the MPC1 does not abolish ketone body accumulation in
the mitochondria, indicating that an undetermined transporter
system or diffusion are involved (Figure 2.6; Paradies and Papa,
1977; Halestrap, 1978; Booth and Clark, 1981; Achanta and Rae,
2017). In mitochondria, ketolysis starts when BDH converts
βHB back to acetoacetate, which is activated to AcAc-CoA by
OXCT1. AcAc-CoA is then degraded by ACAT1 generating Ac-
CoA that can be incorporated into the TCA cycle (Figure 2.3).
Neurons, astrocytes and oligodendroglia have been shown to be
fully capable of using ketone bodies as metabolic fuel in vitro
(Chechik et al., 1987).
Ketone bodies are not toxic to the brain unless associated
with ketoacidosis, a complication linked to diabetes mellitus
(hyperglycemia) or alcoholism where the circulation levels of
ketone bodies increase to > 10 mM. The increase in ketone
bodies arises primarily from metabolism outside the brain and
to date it is unclear if the toxicity is mediated by ketone body
accumulation (ketosis) or acidosis (Fedorovich et al., 2018).
A number of investigations have reported the beneficial effects of
ketosis by regulating astrocytic metabolism, glutamate-glutamine
cycle, glutamine synthetase (GS) activity, the function of vesicular
glutamate transporters, excitatory amino acid transporters
(EAAT), sodium-potassium adenosine triphosphatase (Na+/K+
ATPase), potassium channels (Kir4.1 and KATP), aquaporin-4,
connexins, as well as on astrogliosis (Valdebenito et al., 2016;
Morris et al., 2020). It has also been clearly shown that production
of ketone bodies is used as a signaling mechanism to regulate
food intake (Le Foll and Levin, 2016). While astrocytes exposed to
ketone bodies observe significant morphological changes, these
changes do not seem to correlate with gliosis or inflammation
(Gzielo et al., 2019).
FA OXIDATION (FAO) IN ASTROCYTES:
THE “MISSING LINK”
In addition to ketone bodies, FAs are also energy substrates for
the brain, and unlike ketone bodies, they can diffuse across the
BBB or utilize transport systems for their influx. The main source
of FAs crossing into the brain are non-esterified long chain FAs
(LCFAs, 13–21 carbons) complexed with albumin and circulating
lipoproteins (Hamilton and Brunaldi, 2007). Transport of non-
esterified FAs across the BBB is mediated by passive diffusion (FA
flip-flop) or by FA transporters including FA transport proteins
(FATP1 and 4, with intrinsic acyl-CoA synthetase activity) and
the FA translocase (FAT/CD36) (Figure 3.1; Gnaedinger et al.,
1988; Purdon et al., 1997; Hamilton and Brunaldi, 2007; Ouellet
et al., 2009; Mitchell et al., 2011). The exact transport mechanisms
that mediate the uptake of FAs into neurons or astrocytes are
still unclear. A recent report suggests that FATP1 and 4 mediate
FA uptake in glial cells. Importantly, while neurons are capable
of synthesizing significant amounts of lipids during bioenergetic
excess, they are reported to be dependent on an apolipoprotein
E (ApoE) shuttle system to transfer them to astrocytes to avoid
neurodegenerative phenotypes (Figure 3.6; Liu et al., 2015, 2017).
In the brain, FAO occurs primarily in astrocytes (Edmond
et al., 1987; Auestad et al., 1991; Schonfeld and Reiser, 2013;
Eraso-Pichot et al., 2018). Two recent studies comparing
mitochondrial transcriptomes and proteomes between different
neural cell types corroborated the increased concentration of
enzymes involved in FA metabolism and transport in astrocytes
compared to neurons. Specifically, enzymes associated with LCFA
transport into mitochondria (carnitine palmitoyltransferases or
CPTs) and enzymes that support the requirement of FAO
for anaplerotic reactions and the replenishment of TCA cycle
intermediates (PDK4/2 and PC) where found enriched in
astrocytes (Eraso-Pichot et al., 2018; Fecher et al., 2019). FAO
was also demonstrated to coexist with glycolysis and FAO
enzymes seemed to be more abundant in adult vs. fetal astrocytes
(Eraso-Pichot et al., 2018).
To utilize FAs metabolically (FAO), FAs must be esterified
to CoA in an ATP-dependent process by acyl-CoA synthetases
(ACS), a process that is often linked to, or performed shortly after,
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FA transport by FATPs (Figures 1.3, 4.2; Mashek et al., 2007;
Anderson and Stahl, 2013). In the brain, signaling through
the peroxisome proliferation activated receptor beta (PPARβ,
predominantly expressed in neurons but also glia) increases
the expression of ACS2 (Basu-Modak et al., 1999), in turn
increasing the oxidation of exogenously supplied FAs in
neurons (Marszalek et al., 2004). Astrocytes have an increased
expression of both PPARα and ACS1 compared to neurons
(Basu-Modak et al., 1999), which has been linked to the
upregulation of genes involved in FAO and ketogenic processes
(Cullingford et al., 2002).
Carnitine palmitoyltransferase 1a (CPT1a) transfers the acyl
groups from esterified FAs (acyl-CoA) to L-carnitine (Figure 4.1),
producing acyl-carnitine esters which are transported across
the outer and inner mitochondrial membranes via the voltage-
dependent anion channel (VDAC) and the carnitine/acyl-
carnitine translocase (CACT) transport, respectively. Then, CPT2
converts acyl-carnitine back to acyl-CoA in the mitochondrial
matrix (Figure 4.1; Houten and Wanders, 2010; Panov
et al., 2014; Romano et al., 2017). While both astrocytes
and oligodendrocytes uptake saturated and unsaturated FAs
(Hofmann et al., 2017), CTP1a seems to be found primarily in
astrocytes and neural progenitor cells, while absent in neurons,
microglia, and oligodendrocytes (Jernberg et al., 2017). As
such, carnitine deficiency causes a metabolic encephalopathy
that is characterized by astrocytic swelling and mitochondrial
expansion, corroborating that FAO is an essential metabolic
component of astrocytic function (Kimura and Amemiya, 1990;
Calabrese et al., 2005; Jones et al., 2010). CPT1a activity is
negatively regulated by malonyl-CoA, a molecule synthesized by
Ac-CoA carboxylase (ACC) from cytosolic Ac-CoA. Malonyl-
CoA is also a principal component of FA synthesis, making
this molecule the regulator of FAO and lipogenesis (Figure 4.3;
Foster, 2012). ACC is inhibited by phosphorylation via
the energy sensor adenosine monophosphate (AMP)-activated
protein kinase (AMPK), which links energy deficiency with
mitochondrial FAO (Figure 4.3). Recurrent low glucose exposure
has been shown to activate AMPK and increase FAO dependency
in astrocytes (Weightman Potter et al., 2019). In another study,
astrocyte activation with the ciliary neurotrophic factor (CNTF)
was also shown to activate AMPK and increases FAO and
ketolysis (Escartin et al., 2007). In contrast, upon hypoxic
conditions or high concentrations of FAs, ketogenesis is induced
in astrocytes and this is regulated as well by AMPK signaling
(Blazquez et al., 1999; Takahashi et al., 2014).
In the mitochondria, acyl-CoAs are principally broken down
into Ac-CoA by FAO in a series of sequential reactions that
include: (1) an initial flavin adenine dinucleotide (FAD)-
dependent dehydrogenation of acyl-CoAs by acyl-CoA
dehydrogenase (ACD or ACAD) that generates FADH2; (2)
a subsequent hydration step mediated by enoyl-CoA hydratase
(ECH) forming 3-hydroxy(OH)acyl-CoA; (3) generation of
3-ketoacyl-CoA via 3-OHacyl-CoA dehydrogenase (HAD) in
an NAD+-dependent manner regenerating NADH; and (4)
cleavage and release of Ac-CoA via thiolase I leaving an acyl-CoA
two carbon atoms shorter that re-enters the pathway. The last
three steps are carried by a heteroctamer protein complex called
the mitochondrial trifunctional protein composed of alpha
[HADHA (ECH/HAD)] and beta [HADHB (thiolase)] subunits
(Figure 2.2; Houten and Wanders, 2010; Panov et al., 2014;
Romano et al., 2017). In the brain, 95% of HADHA co-localizes
with the astrocyte biomarker GFAP (Sayre et al., 2017) and ACD
is also predominantly find in astrocytes (Fecher et al., 2019).
For FAs/acyl-CoAs with odd numbered carbons, FAO will
yield propionyl (Prop)-CoA rather than Ac-CoA from the final
carbons of the acyl-CoA. Prop-CoA can either be converted
to succinyl (Succ)-CoA in an ATP-dependent manner by a
series of reactions providing an anaplerotic input to the TCA
cycle, or act as a co-substrate in the ketolytic conversion of
AcAc-CoA to acetoacetate by OXCT1 (Figure 2.3). In the event
that the β-carbon of a FA is methylated, α-oxidation occurs
to remove one carbon unit as formic acid [formic acid is
converted to carbon dioxide (CO2)], shifting the methylated
carbon from the β to α position, allowing β-oxidation to resume.
The steps in α-oxidation include: (1) hydroxylation of the
α-carbon by phytanoyl-CoA hydroxylase (PhyH/Pahx) utilizing
the conversion of αKG to succinate as a driving force; (2)
decarboxylation by 2-hydroxyphytanoyl-CoA lyase (2-HPCL)
releasing formyl-CoA and a fatty aldehyde; (3) oxidation of the
fatty aldehyde by aldehyde dehydrogenase generating NADH
and an acyl-CoA one carbon shorter than the original product
(Jansen and Wanders, 2006).
A large quantity of ATP can be generated from FAO (one
molecule of palmitic acid provides approximately 115 ATPs vs.
32 ATPs generated from glucose oxidation). Despite its high-
energy potential, FAs have long been considered a poor energy
substrate in the brain. The brain as a whole was thought to be
limited in FAO capacity as thiolase I, ACD and ECH activities
are 0.7, 50, and 19% that of the heart mitochondria (Yang et al.,
1987), though it must be noted that glial and neuronal forms
of the enzymes were not assayed independently (Figure 2.2).
While there are three known carnitine palmitoyltransferase 1
(CPT1) isoforms, CPT1a has a low expression in the whole brain
and is not expressed in neurons (Jernberg et al., 2017), CTP1b
is not expressed in the brain (Obici et al., 2003; Lavrentyev
et al., 2004), and CPT1c localizes exclusively to the endoplasmic
reticulum in neurons and has not been shown to participate
in FAO (Wolfgang et al., 2006; Sierra et al., 2008) but has
been implicated in ROS management (Lee and Wolfgang, 2012).
Lower CPT1a expression and activity restricts mitochondrial
oxidation of FAs in neurons (Bird et al., 1985), except for those
with 12 or fewer carbons, which can passively diffuse across
the mitochondrial inner membrane (Figures 1.3, 2.2, 4.2). Yet
the brain has been demonstrated to metabolize carbons from
FAs in vivo, accounting for ∼20% of the total Ac-CoA pool
when labeled octanoate is supplied to the bloodstream (Ebert
et al., 2003), which occurs predominantly in astrocytes, based
on comparisons of astrocytes, oligodendrocytes and neurons in
primary cultures (Edmond et al., 1987).
Astrocytes have a high buffering capacity against ROS
compared to neurons (Sun et al., 2006), and FAO is proposed
to induce higher amounts of ROS formation. One cycle of
FAO generates one molecule of FADH2 and NADH, increasing
the total FADH2/NADH ratio per Ac-CoA created compared
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to glycolysis (Figure 2.2). When ACD transfers electrons from
acyl-CoA to FAD, it is coupled to the subsequent transfer of
electrons from the resultant FADH2 to the electron transferring
flavoprotein (ETF). The follow-up transfer of electrons from
ETF to ubiquinone (coenzyme Q) by ETF dehydrogenase
creates a backpressure of electrons flowing through complex
I (donated from NADH) and complex II (donated from
succinate) to ubiquinone that enhances the probability of
leakage and formation of ROS (Figure 2.5). Thus, it has
been proposed that restricting FAO protects neurons against
oxidative damage beyond the stages of development (Schonfeld
and Reiser, 2013, 2017). In the brain, inhibition of FAO by
methyl palmoxirate has been shown to reduce the concentrations
of non-enzymatically oxidized metabolites derived from poly-
unsaturated FAs (PUFA), indicating that ROS are being generated
from FAO (Chen et al., 2014).
However, the mechanism of ROS generation from FA
substrates is not universal, and depends upon the length and
structure of the FA. Very long chain FAs (VLCFAs, 22 or more
carbons) that are not esterified have been shown to integrate
into artificial phospholipid bilayers, desorpting at slower rates
than shorter FAs and disrupting membrane fluidity (Ho et al.,
1995). This integration and disruption by VLCFAs has been
shown to occur in the inner mitochondrial membrane, decreasing
the membrane potential by protonophoric activity, and reducing
ROS generated from reverse electron transport (RET) (Hein
et al., 2008). The protonophoric property, and its resulting
decrease in ROS from hyperpolarization, has been demonstrated
in medium chain FAs (MCFAs 6–12 carbons) (Korshunov
et al., 1998), LCFAs and branched chain FAs (Schonfeld and
Wojtczak, 2007). This protonophoric capacity of FAs decreases
as the length of the FA decreases (Schonfeld and Wojtczak,
2016), while branched FAs such as phytanic acid show an
increased protonophoric activity compared to their straight chain
FA counterparts (Komen et al., 2007; Schonfeld and Reiser,
2016). Additionally, application of carnitine esters as substrates
demonstrated that RET was not occurring in the mitochondria,
furthering that RET is not a prominent form of ROS production
during FAO (Schonfeld et al., 2010).
While protonophoric properties of FAs can mitigate the
effects of hyperpolarization/RET, FAs can promote ROS
generated through forward electron transport and by interfering
with electron transport. Isolated mitochondria increased ROS
production proportionally to FA exposure in the presence of the
recoupling agent carboxyatractyloside (Schonfeld and Wojtczak,
2007) and during uncoupling with CCCP (Cocco et al., 1999),
indicating that ROS was being generated independently of the
protonophoric effects. Interestingly, branched phytanic acid and
poly unsaturated arachidonic acid demonstrated stronger ROS
effects than unbranched saturated FAs in the aforementioned
studies (Cocco et al., 1999; Schonfeld and Wojtczak, 2007).
Mitochondria exposed to low concentrations of LCFAs were
also found to generate ROS at complex III and in a membrane
potential-independent manner at the ETF-ETF-oxidoreductase
(Seifert et al., 2010). As described in Schonfeld and Wojtczak
(2008), despite the evidence of electron transfer interference by
FAs, the mechanism is not well understood.
FAs are stored within cells as energy-rich triacylglycerides
localized in lipid droplets, removing excess free FAs from
the cytoplasm, which are toxic and disrupt mitochondrial
membrane integrity. In addition, LDs deliver FAs into
mitochondria for their consumption as an alternative energy
source during periods of nutrient depletion. Neurons do
not typically make LDs, while astrocytes do (Schonfeld
and Reiser, 2013), and it has been shown that toxic FAs
produced in hyperactive neurons are transferred to astrocytic
LDs where they are consumed by via mitochondrial FAO
(Ioannou et al., 2019). Importantly, under nutrient deprivation
conditions, the survival of astrocytes depends on LD-fueled FAO
(Cabodevilla et al., 2013).
Peroxisomes are located throughout the brain but are
primarily found in astrocytes and oligodendrocytes (Troffer-
Charlier et al., 1998). VLCFAs cannot be transported into the
mitochondria via the carnitine shuttle and thus, are broken down
first by peroxisomes. As in mitochondria, FAs must be esterified
to CoA before undergoing FAO in peroxisomes (Figures 1.4, 4).
Because peroxisomes lack an electron transport chain (ETC),
electrons from FADH2 are transferred directly to O2 creating
hydrogen peroxide (H2O2) that is scavenged by catalase (CAT).
Within the peroxisome, FAs are shortened to Ac-CoA, Prop-CoA,
and a wide range of LCFAs, MCFAs, and short chain FAs (SCFAs,
6 carbons or less). A variety of export systems exist within the
peroxisomes, each with different affinities for different lengths of
FAs, including carnitine-transferases [carnitine acetyltransferases
(CRATs), carnitine octanoyltransferases (CROTs)], and thiolases
[acyl-CoA thioesterases (ACOTs)] (Figure 1.4; Antonenkov and
Hiltunen, 2012). Additionally, peroxisomes have been shown to
possess ketogenic enzymes, implicating peroxisomes as another
potential source of ketone bodies and cholesterol (Hovik et al.,
1991; Antonenkov et al., 2000; Olivier et al., 2000).
Dysfunction of peroxisomal processes has been linked
to demyelination, oxidative stress, inflammation, cell death,
and abnormalities in neuronal migration and differentiation
(Trompier et al., 2014). Defects in the ATP binding cassette
subfamily D member 1 (ABCD1) transporter that translocates
very LCFAs into peroxisomes (Figure 1.4), leads to the
accumulation of these fats in cells and tissues. VLCFAs and
branched chain FAs can interfere directly with the ETC by
opening the permeability transition pore, disrupting Ca2+
balance and depolarizing the mitochondria (Hein et al., 2008;
Kruska et al., 2015; Schonfeld and Reiser, 2016). LCFAs activate
PPAR transcription factors that stimulate both FAO and
ketogenesis as well as mitochondrial and peroxisome biogenesis.
Recent reports have also demonstrated that peroxisome
biogenesis requires the generation of pre-peroxisomes from
mitochondrial derived vesicles (Sugiura et al., 2017).
Previous studies have demonstrated that astrocytes have
the machinery to metabolize MCFAs, LCFAs and VLCFAs as
evidenced not only by the higher expression of FAO-related
enzymes but also by the higher content of peroxisomes (Fecher
et al., 2019; Fitzner et al., 2020). For example, the MCFA
octanoate (C8) that composes 13% of the normal free fatty
acid pool and can cross the BBB is avidly metabolized by
astrocytes (Ebert et al., 2003). In brain slices, astrocytes have
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been shown to contain palmitate (C16) and oleate (C18) LCFAs
(Hofmann et al., 2017).
Alterations in FA metabolism in astrocytes have been reported
in different disorders. A recent report demonstrated that in
a Huntington’s disease mouse model, astrocytes within the
striatum consume FAs as an alternative fuel, which results in
increased oxidative damage (Polyzos et al., 2019). Astrocytes
carrying the ApoE4 allele, the strongest genetic risk factor for the
development of Alzheimer’s disease, observe profound alterations
in FA metabolism and LD formation (Farmer et al., 2019).
Stimulation of FAO protects against ischemic injury as well
(Sayre et al., 2017). Pharmacological modulation of FAO has
been suggested as a therapeutic approach against glioblastoma
cells (Lin et al., 2017). Many chemical compounds are considered
to be inhibitors or activators of FAO enzymes. However, the
current knowledge on their specificities, potencies and metabolic
impacts is limited and controversial. For example, at high
concentrations, etomoxir, the inhibitor of CPT1a, has off-target
effects linked to the inhibition of the ETC (Yao et al., 2018).
Other FAO modulators include the CPT1a inhibitor oxfenicine
and PPARs agonists/antagonists. Accordingly, the impairment in
FAO observed in astrocytes derived from induced pluripotent
stem cells isolated from Alzheimer’s disease patients is corrected
by PPARβ/δ agonists (Konttinen et al., 2019). The specificity of
the metabolic modifiers ranolazine (Ranexa) and trimetazidine,
initially described as partial FAO inhibitors that target the HAD
(or 3-KAT) activity of the trifunctional protein HADHA, has been




Astrocyte processes extending to synaptic clefts play an
important role in regulating synaptic transmission, particularly
glutamatergic signaling. After its vesicle-mediated release, the
excitatory neurotransmitter glutamate is taken from the synaptic
cleft by astrocytes in a Na+ dependent manner via EAAT1
(glutamate aspartate transporter, GLAST) or EAAT2 (glutamate
transporter 1, GLT-1) (Figure 3.4). In the cytosol, glutamate
is then converted into non-excitatory glutamine via GS, and
transferred back to neurons via the Na+-coupled neutral amino
acid transporters (SNATs) to be converted back into glutamate in
neurons via phosphate-activated glutaminase (PAG) (Figure 3.4;
Norenberg and Martinez-Hernandez, 1979; Anderson and
Swanson, 2000; Schousboe et al., 2013; Leke and Schousboe,
2016). In astrocytes, despite the presence of a weak mitochondrial
targeting sequence, GS is localized in the cytosol because the
mitochondrial membrane potential is not negative enough to
drive GS into the mitochondria (Figures 1.6, 3.2; Matthews
et al., 2010). Neurons lack PC activity (Yu et al., 1983),
restricting their ability to replenish TCA intermediates lost
during neurotransmitter release (anaplerotic reaction). Thus, the
glutamate-glutamine cycle between neurons and astrocytes, not
only terminates/modulates glutamatergic signaling, preventing
excitotoxicity triggered by excessive or prolonged exposure to
glutamate, but it also replenishes the neurotransmitter pool in
neurons (Figure 3.4; Belanger et al., 2011).
Not all the glutamate taken from the synaptic cleft
by astrocytes becomes glutamine. There is evidence that a
significant portion is incorporated into the TCA cycle via
oxidative metabolism (Figure 2.4). Glutamate transport into the
mitochondria is mediated via the aspartate/glutamate carrier
antiporter (AGC or Aralar 1) or via the glutamate carrier (GC1
or GC2), a symporter for glutamate and H+. Controversy still
exists about the contribution of AGC to the uptake of glutamate
in astrocytic mitochondria, as it has been shown to be primarily
expressed in neurons. However, while the AGC activity in
astrocytes corresponds only to 7% of the total brain AGC activity,
it is calculated to be twice the minimum required for glutamate
production and degradation (Figure 2.6; Hertz, 2011). AGC is
also central to the malate-aspartate shuttle (Figure 1.6), a system
that allows the transfer of NADH electrons generated in the
cytosol, from processes such as glycolysis, to the mitochondria
(Amoedo et al., 2016). On the other hand, knockdown of GC1
suggests that this carrier is the main gate for net glutamate
entry into mitochondria for oxidative metabolism in astrocytes
(Figure 2.6; Goubert et al., 2017).
In the mitochondria, glutamate is metabolized to αKG by
transamination via aspartate aminotransferase (GOT2), and
to a lesser extent by alanine (ALAT) and branched chain
aminotransferases (BCAT) (Figure 2.4). In addition, αKG can
also be synthesized from glutamate via glutamate dehydrogenase
(GDH), which is also a source of NADPH. While glutamate
transamination via GOT2 generates a truncated TCA cycle due
to the requirement of OAA as a co-substrate, GDH-mediated
dehydrogenation can serve as an anaplerotic reaction to replenish
TCA intermediates (Figures 2.1, 2.4; Sonnewald et al., 1993;
Olsen and Sonnewald, 2015; McKenna et al., 2016). Astrocytes
deficient in GDH increase their reliance on GOT2 and their
glycolytic input to PC, which is paralleled by an accumulation
of intracellular glutamate, underlying the importance of GDH
in anaplerosis (Nissen et al., 2015; Pajecka et al., 2015). It
should be noted that humans, unlike most other animals
including mice and rats, have an additional GDH2 isoform that
is expressed solely in astrocytes. Expression of GDH2 in rat
cortical astrocytes increased glutamate uptake and metabolism,
reducing their dependence on glucose and increasing their
capacity to utilize branched chain amino acids (BCAA) (Nissen
et al., 2017). Importantly, glutamate to glutamine metabolism
is not determined by the extracellular glutamate concentration.
However, the entry of glutamate into the TCA cycle seems to
be triggered by high extracellular glutamate concentrations (high
µM) (McKenna et al., 1996).
The homeostasis of the inhibitory neurotransmitter
γ-aminobutyric acid (GABA) is similarly linked to the glutamate-
glutamine cycle. GABA is synthesized in neurons from the
decarboxylation of glutamate by glutamate decarboxylase
(GAD). After its vesicular release, GABA is uptaken by astrocytes
through the GABA transporter (GAT3) (Figure 3.4). GABA
is then metabolized by GABA transaminase (GABA-T) with
αKG as cofactor to produce succinate semialdehyde (SSA) and
glutamate (Figure 2.4). SSA is metabolized to succinate via
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SSA-dehydrogenase (SSADH), which can then be incorporated
back into the TCA cycle. This anaplerotic addition of succinate
compensates the cataplerotic loss of carbons from the generation
of glutamate by the GABA-T (Figure 2.1; Schousboe et al., 2013).
In addition to metabolism, evidence indicates that astrocyte
mitochondrial bioenergetics are important for the regulation
of neurotransmitter balance. Both glutamate and GABA
uptake systems in astrocytes are driven by Na+ gradients
that are established by the electrogenic action of the Na+/K+
ATPase (Figure 3.4). PC and GS activities also require ATP
as well, and are critical enzymes in replenishing neuronal
glutamine/glutamate (FIgures 2.1, 3.4). Importantly, it
has been demonstrated that mitochondria co-localize with
EAAT1/2 and glycolytic enzymes on the plasma membrane
of astrocytes (Genda et al., 2011; Bauer et al., 2012), and that
glutamate transporters physically interact with the Na+/K+
ATPase (Figure 3.6; Rose et al., 2009), suggesting that while
mitochondrial-derived ATP is not required for astrocyte survival
(Supplie et al., 2017), functional mitochondrial metabolism
is important for neurotransmitter uptake and homeostasis
(Figures 3.2, 3.4, 3.6). In fact, astrocyte processes enveloping
synaptic terminals contain abundant mitochondria (Jackson
et al., 2014; Stephen et al., 2015; Jackson and Robinson, 2018),
and inhibition of mitochondrial function by fluorocitrate in
astrocytes increases glutamate excitotoxicity in co-cultures with
neurons (Voloboueva et al., 2007).
MITOCHONDRIAL METABOLISM IN
ASTROCYTES AND REDOX BALANCE
Astrocytes contain higher levels of endogenous antioxidants
and antioxidant systems being more resistant to oxidative
stress than neurons, which is explained by the activation of
the antioxidant response via the nuclear factor erythroid-2-
related factor 2 (Nrf2) transcription factor (Shih et al., 2003;
Jimenez-Blasco et al., 2015). Astrocytes also have higher levels
of NADPH and G6PD (glucose 6-phosphate dehydrogenase)
glucose 6-phosphate dehydrogenase (G6PD) (Garcia-Nogales
et al., 2003). In the mitochondria, superoxide anion (O2•−) is
generally considered to be generated in the matrix by electron
leakage from complex I (Grivennikova and Vinogradov, 2006),
and in both the matrix and the intermembrane space (IMS)
by electron leakage from complex III (Chen et al., 2003). O2•−
generated in the matrix and the IMS has been proposed to
be released to the cytosol via the mitochondrial permeability
transition pore (mPTP) (Wang et al., 2008) and the VDAC (Han
et al., 2003), respectively. However, at least 10 different additional
sites for O2•−/H2O2 production in the mitochondria have been
described. The relative and absolute contribution of specific sites
in the mitochondria to the production of ROS seems to depend
on the availability of the substrate being oxidized (Cardoso et al.,
2012; Quinlan et al., 2013). Of importance, one ROS can lead
to the generation of distinct more reactive species. As such,
O2•− can be dismutated in an enzymatic (superoxide dismutases
[SODs]) or non-enzymatic manner to H2O2. While H2O2 is
thought to diffuse across membranes, it has also been reported
that it can be transported by aquaporins (Bienert et al., 2006,
2007). Surprisingly, astrocytes have less efficient mitochondrial
respiration and increased ROS formation when compared to
neurons, in part due to a lower incorporation of complex I into
supercomplexes in astrocytes caused by lower expression of the
NADH-ubiquinone oxidoreductase core subunit S1 (NDUFS1)
(Lopez-Fabuel et al., 2016).
The physiological role of increased mitochondrial ROS
production in astrocytes had not been explored before, but
an elegant recent investigation using mitochondria-targeted
antioxidants demonstrated that high ROS production in
astrocytes regulates GSH metabolism via Nrf2, and conversely,
represses glucose metabolism via the PPP to decrease NADPH-
dependent ROS production by NADPH-dependent oxidases
(Nox1 and 2), which together modulate the redox status and
survival of neurons (Vicente-Gutierrez et al., 2019). Interestingly,
glutamate (N-methyl-d-aspartate) receptors (NMDA-R) couple
neurotransmission to Nrf2 activation, where NMDA-R signaling
in astrocytes promotes Nrf2 phosphorylation by cyclin-
dependent kinase 5 (Cdk5) and its translocation to the nucleus,
a novel mechanisms of intercellular feedback communication
from neurons to astrocytes (Jimenez-Blasco et al., 2015).
While both neurons and astrocytes can synthesize GSH,
astrocytes have been reported to protect neurons via regulation
of GSH metabolism (Chen et al., 2001; Shih et al., 2003). This
protective effect is thought to be dependent on the supply of
cysteine from astrocytes as a precursor for de novo GSH synthesis
(Dringen et al., 1999; Wang and Cynader, 2000), and in part
due to neurons being unable to uptake significant amounts of
extracellular cystine (Sagara et al., 1993; Kranich et al., 1996).
GSH has been proposed to be released from astrocytes via
the ATP-binding cassette transporters subfamily C member 1
transporter (ABCC1, or multidrug-resistance-associated protein
1 [MRP1]) (Figures 1.6, 3.2; Hirrlinger et al., 2002; Hirrlinger and
Dringen, 2005). Indeed, inhibition of MRP1 has been reported
to reduce the extracellular accumulation of GSH in cultured
astrocytes (Hirrlinger and Dringen, 2005). We have failed to
observe a reciprocal accumulation of GSH in astrocytess when
MRP1 activity is reduced (unpublished data), but this effect might
be ascribed to feedback inhibition of GSH synthesis by GSH.
Once released, GSH is degraded by the γ-glutamyl
transpeptidase (γGT) to produce l-cysteine-l-glycine (CysGly)
(Dringen et al., 1997). CysGly is cleaved further by the neuronal
aminopeptidase N (ApN) into the amino acids glycine and
cysteine that are taken up by neurons for de novo GSH synthesis
via the Na+-Cl−-dependent glycine transporter 1 (GlyT1) and
EAAT3, respectively (Figures 3.2, 3.3; Dringen et al., 1999,
2001; Aoyama et al., 2008; Belanger et al., 2011). The export of
GSH should imply a loss of carbons that must be replenished
in astrocytes to maintain cellular redox homeostasis. Cysteine
acquisition in astrocytes is mediated by the Na+-dependent
XAG-/EAAT3 and -independent Xc-/xCT uptake systems, but
their exact contribution is still under debate (Shanker et al.,
2001; Seib et al., 2011). De novo synthesis via the TSP pathway
is also an important source for cysteine in astrocytes, and was
shown to be upregulated and utilized during oxidative stress
(Figures 3.2, 4.5; Vitvitsky et al., 2006). In most cells, cysteine is
Frontiers in Neuroscience | www.frontiersin.org 12 November 2020 | Volume 14 | Article 536682
fnins-14-536682 October 30, 2020 Time: 15:47 # 13
Rose et al. Astrocytes’ Mitochondrial Metabolism and Brain Function
considered the limiting substrate for GSH synthesis. However,
glutamate might also be considered a limiting in astrocytes as
it is metabolized to glutamine (Figure 1.6). Because glutamate
synthesis depends on mitochondrial anaplerotic metabolism,
mitochondrial function might as well be essential for GSH
homeostasis (Figure 2.1, 2.4). Interestingly, GSH depletion
upregulates mitochondrial activity and expression of complex
I in astrocytes (Vasquez et al., 2001), but the exact mechanisms
that regulate this phenomenon are still unclear.
Central carbon metabolism in the mitochondria is also
important for the maintenance of redox balance as it fuels the
regeneration of NADPH. In addition to the anaplerotic activity
of GDH mentioned above (Figure 2.4), within the mitochondria,
the malic enzyme (ME) and isocitrate dehydrogenase isoform 2
(IDH2) regenerate NADPH coupled to the formation of OAA
and αKG, respectively (Figures 2.1, 2.6). While higher levels
of mitochondrial IDH activity have been reported in astrocytes
(Minich et al., 2003), conflicting results exists in regards to
the activity levels of mitochondrial ME (McKenna et al., 1995;
Vogel et al., 1998). Metabolic flux analysis has also demonstrated
that transfer of H from NADH via nicotinamide nucleotide
transhydrogenase (NNT) contributes to the regeneration of the
mitochondrial NADPH pool (Figure 2.5; Lewis et al., 2014),
which is highly expressed in the brain (Arkblad et al., 2002).
A comparative analysis demonstrated that these three metabolic
pathways actively contribute to NADPH replenishment in brain
mitochondria (Vogel et al., 1999), but other studies have reported
a predominant role for the NNT pathway, particularly under
metabolic stress (Lopert and Patel, 2014).
Folate metabolism supports one-carbon metabolism that
serves to activate and transfer one-carbon units for biosynthetic
processes. Mammals lack the capacity for folate synthesis whose
requirements are largely met through dietary sources. Folate
is not biologically active, but it is readily reduced in the
intestinal mucosa or liver and converted into tetrahydrofolate
(THF) molecules, such as 5-methyl-THF and 5-formy-THF. 5-
methylTHF is the predominant form of folate in the blood
and its transport in the brain across the BBB is mediated by
the folate receptor alpha (FRα/FOLR1), the H+-coupled folate
transporter (PCFT/SLC46A1), and the reduced folate carrier
(RFC/SLC19A1), but whether the same mechanisms mediate
folate transport in neural cells including astrocytes is unclear
(Figure 3.1; Alam et al., 2020). Furthermore, because there is no
dihydrofolate reductase in the brain to catalyze the formation of
5-methyl-THF (Wu and Pardridge, 1999), 5-methylTHF rather
than folate is present in the CSF. Carrier-mediated energy-
dependent transport of 5-methyl- and 5-formyl-THF has been
described in astrocytes (Cai and Horne, 2003).
While serine can be acquired from the diet, central carbon
metabolism makes substantial contribution to serine availability
and as a consequence to folate metabolism in both the
cytosol and the mitochondria (Figure 4.4). THF and serine
are transported into the mitochondria via SLC25A32 (Lawrence
et al., 2011) and sideroflexin-1 (SFXN1) (Kory et al., 2018),
respectively. Mitochondrial serine hydroxymethyltransferase 2
(SHMT2) transfers the β-carbon of serine to THF, generating
5,10-methylene-THF that can also be produced from glycine
by the activity of glycine decarboxylase (GLDC), an abundant
enzyme in astrocytes (Figure 4.4; Li et al., 2018). GLDC
deficiency induces neural tube defects and hydrocephaly (Pai
et al., 2015; Leung et al., 2017; Santos et al., 2020). The
bifunctional enzyme methylenetetrahydrofolate dehydrogenase
2 (MTHFD2) or MTHFD2-like (MTHFD2L) then catalyzes
the sequential production of 5,10-methenyl-THF and 10-
formyl-THF. Finally, 10-formyl-THF is cleaved by MTHFD1L
to generate formate, which can be exported to the cytosol
(Figure 4.4). 10-formyl-THF can also be metabolized by 10-
formyl-THF dehydrogenase (ALDH1L2). During this process
both MTHFD2(L) and ALDH1L2 generate NADPH (Yang and
Vousden, 2016; Figure 4.4). As such, knockdown of MTHFD2
decreases cellular NADPH/NADP+ and GSH/GSH disulfide
(GSSG) ratios, and sensitizes cells to oxidative stress (Fan et al.,
2014). The cytosolic counterpart of ALDH1L2, ALDH1L1 is
expressed abundantly in astrocytes (Neymeyer et al., 1997; Foo
and Dougherty, 2013). ALDH1L2 mutations seem to induce
astrocytic stress (Sarret et al., 2019). Interestingly, complex I
deficiency has been shown to decrease NADPH synthesis via
ALDH1L2 due to the impaired generation of NAD+ (Balsa
et al., 2020). Despite the bidirectionality of this pathway, most
of the cytosolic one-carbon units derived from serine are
catabolized in the mitochondria, as this seems to be favored
by the more oxidative mitochondrial redox potential, when
compared to the cytosol. However, when the mitochondrial
folate pathway is lost the directionality of the cytosolic one-
carbon flux is reversed to compensate the synthesis of NADPH
(Ducker et al., 2016).
In the cytosol, the trifunctional enzyme MTHFD1 regenerates
THF and the intermediate 5,10-methylene-THF links the
folate pathway and thus, central carbon metabolism, with the
remethylation of homocysteine within the TSP. As mentioned
before the TSP is an important source for cysteine in astrocytes
(Figures 3.2, 4.5; Vitvitsky et al., 2006). While remethylation
of homocysteine to methionine can be accomplished by
the activity of methionine synthase, in the liver and kidney
mitochondria, betaine-homocysteine S-methyltransferase
(BHMT) also produces methionine from homocysteine, linking
the mitochondrial oxidation of choline to betaine with the TSP
(Figure 4.5). Brain genetic variants of BHMT have been linked
to schizophrenia (Ohnishi et al., 2019). However, the presence of
BHMT and its significance to the remethylation of homocysteine
hasn’t been confirmed in astrocytes (Kempson et al., 2014).
CONCLUSION AND PERSPECTIVES
The scientific process has been aptly described as blind people
attempting to describe an elephant while only focusing on
particular parts of the animal. Each person is contextually correct,
but only when the data is combined can we achieve an accurate
understanding of the whole. While there are far more parts
of the proverbial elephant to explore to complete the picture,
the recent evidence indicates that we must adjust our current
understanding of brain metabolism, particularly as it pertains to
astrocytes and neurons.
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Current research indicates that metabolism in the brain
extends far beyond glucose. FAs, and their derived ketone bodies,
are important sources of bioenergetic potential for the brain,
particularly during development, as shown by the experiments
in vivo and in vitro that follow its oxidation and integration into
biomolecules. Glutamate is more than just a neurotransmitter
kept in strict stoichiometry by the glutamate-glutamine cycle;
it is a resource the brain uses for amino acid synthesis by
transamination, for redox balance by generation of NADPH, and
for anaplerosis to maintain the TCA cycle.
The brain is far from a homogeneous body of cells, and
the literature paints a clear picture of metabolic specialization
and intracellular cooperation/dependence. In this review,
we have centered our attention to astrocytic mitochondrial
metabolism and its role in the regulation of brain bioenergetics,
neurotransmission and redox balance via neuronal-astrocyte
metabolic interactions. Astrocytes have been demonstrated
to be functional without OXPHOS in vivo, to provide a
GSH-dependent protective effect to neurons, to function as
neutralizing and cycling agents of glutamatergic/GABAergic
signaling, and to be synthesizers/exporters of OXPHOS
bioenergetic molecules (lactate/ketone bodies). In contrast,
neurons have a metabolic specialization toward OXPHOS,
spurning FAO, restricting glucose oxidation while maintaining
the PPP for redox homeostasis, and limiting their ability
to conduct mitochondrial biosynthesis due to a lack of
pyruvate carboxylase for anaplerosis. Together, neurons
shoulder the bioenergetic burden of neurotransmission by
controlled alterations in cell potential, while astrocytes conduct
biosynthesis and high ROS oxidative processes to supplement
neuronal functions.
The key organelle in this differential specialization is the
mitochondria. While the broad mitochondrial role in OXPHOS
is well known in mammalian cells, specialization is evident
within neurons and astrocytes. Astrocytes restrict the conversion
of pyruvate to Ac-CoA by their phosphorylation of PDH,
limiting their utilization of glucose for OXPHOS but instead
directing these carbons to biosynthesis through the TCA cycle
by PC. Additionally, the efficiency of the astrocyte ETC is
far less than neurons, resulting in higher ROS generation in
astrocyte compared to neurons. Astrocytic mitochondria have
been demonstrated to utilize FAO for the production of ketone
bodies, a process that has not been shown to be significant
in neurons. Further, evidence shows that astrocytes localize
mitochondria to endfeet processes in conjunction with glutamate
transporters and enzymes related to glycolysis. Coupled with the
evidence that OXPHOS is not required in astrocytes in vivo, this
paints a unique picture for astrocyte mitochondria compared
to the prototypical mammalian cell. It is a mitochondria
specializing in synthesis at the expense of OXPHOS, while
the neuronal mitochondria specializes in OXPHOS at the
expense of synthesis.
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